Lars Rydén

35.2k citations
119 papers · 11.0k · 7 hit papers · h-index 29

Impact in

    • Atrial Fibrillation Management and Outcomes
    • Acute Myocardial Infarction Research
    • Cardiac Arrhythmias and Treatments
    • Cardiac electrophysiology and arrhythmias
    • Cardiovascular Function and Risk Factors
    • Heart Failure Treatment and Management
    • Cardiac pacing and defibrillation studies

Papers in

    • Cardiac pacing and defibrillation studies 23
    • Cardiac Arrhythmias and Treatments 22
    • Cardiovascular Function and Risk Factors 19
    • Atrial Fibrillation Management and Outcomes 17
    • Cardiac electrophysiology and arrhythmias 16
    • Heart Failure Treatment and Management 12
    • Blood Pressure and Hypertension Studies 10

Lars Rydén

115 papers receiving 10.4k citations

Lars Rydén's Hit Papers

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation 2011 · 712 citations
7120+11+22Years since publication10002.0k3.0k

Peers

Lars Rydén
Comparison fields: 5 of 147
  • Cardiology and Cardiovascular Medicine 8.6k
  • Internal Medicine 596
  • Endocrinology, Diabetes and Metabolism 1.9k
  • Radiology, Nuclear Medicine and Imaging 2.0k
  • Surgery 1.7k
Replace Philip R. Liebson with:
Philip R. Liebson United States
José Carlos Nicolau Brazil
Susan J. Zieman United States
Kim Fox United Kingdom
John A. Ambrose United States
Kazuo Kimura Japan
Bariş Gencer Switzerland
W B Kannel United States
William E. Boden United States
José López‐Sendón Spain
Lars Rydén relative to Philip R. Liebson United States Philip R. Liebson's profile →
Citations per field
00.5×1.5×2.4×
Philip R. Liebson · 1×
Citations per year

Countries citing papers authored by Lars Rydén

Since Specialization
Citations

This map shows the geographic impact of Lars Rydén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Rydén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Rydén more than expected).

Fields of papers citing papers by Lars Rydén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Rydén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Rydén. The network helps show where Lars Rydén may publish in the future.

Co-authors

The 25 scholars most cited alongside Lars Rydén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lars Rydén Line = papers co-authored together Lars Rydén links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction
Hit paper breakdown →
20003778
2
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
Hit paper breakdown →
2006839
3
Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study
Hit paper breakdown →
2002796
4
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
Hit paper breakdown →
2011712
5
Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial Infarction
Hit paper breakdown →
1992676
6
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
Hit paper breakdown →
2011649
7
Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction
Hit paper breakdown →
1999621
8 2006285
9 1982215
10 2004206
11 1988189
12 1988156
13 2007125
14 2019122
15 1999108
16 198992
17 198582
18 198071
19 198565
20 200756

About Lars Rydén

Lars Rydén is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 119 papers that have together received 11.0k indexed citations. Recurring topics across this work include Cardiac pacing and defibrillation studies (23 papers), Cardiac Arrhythmias and Treatments (22 papers), Cardiovascular Function and Risk Factors (19 papers), Atrial Fibrillation Management and Outcomes (17 papers), Cardiac electrophysiology and arrhythmias (16 papers), Heart Failure Treatment and Management (12 papers), Cardiac Imaging and Diagnostics (11 papers) and Blood Pressure and Hypertension Studies (10 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (8.6k citations), Internal Medicine (596 citations), Endocrinology, Diabetes and Metabolism (1.9k citations), Radiology, Nuclear Medicine and Imaging (2.0k citations) and Surgery (1.7k citations). Lars Rydén has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Michał Tendera, Maarten L. Simoons, Magnus Öhman, Elliott M. Antman, Werner Klein, José Luis López Sendón, Jean‐Pierre Bassand, Anna Norhammar, Hans Wedel and Klas Malmberg. Their work appears in journals such as European Heart Journal, Pacing and Clinical Electrophysiology, Journal of the American College of Cardiology, Cardiovascular Research and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact